title: Letter by Van de Werf et al regarding article, "using dabigatran in patients with stroke: a practical guide for clinicians".
authors.forename: Frans
authors.initials: F
authors.lastname: Van de Werf
authors.forename: Stuart J
authors.initials: SJ
authors.lastname: Connolly
authors.forename: Arie Pieter
authors.initials: AP
authors.lastname: Kappetein
authors.forename: Martina
authors.initials: M
authors.lastname: Brueckmann
authors.forename: Michael J
authors.initials: MJ
authors.lastname: Mack
authors.forename: Christopher B
authors.initials: CB
authors.lastname: Granger
authors.forename: John
authors.initials: J
authors.lastname: Eikelboom
mesh_terms: D000991:Antithrombins / Q000627:therapeutic use*; D001562:Benzimidazoles / Q000627:therapeutic use*; D006801:Humans; D020521:Stroke / Q000188:drug therapy*; D015091:beta-Alanine / Q000031:analogs & derivatives*
chemical_list: D000991:Antithrombins; D001562:Benzimidazoles; D015091:beta-Alanine